Medicine
Bupivacaine 133 mg/10 mL liposomal injectable suspension
Bupivacaine 133 mg/10 mL liposomal injectable suspension is a generic prescription medicine for infiltration use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store bupivacaine liposome injectable suspension vials refrigerated between 2°…
Key facts
- Active ingredient (INN)
- Bupivacaine
- Brand
- Sold under the generic name
- Strength
- 133 mg/10 mL
- Dosage form
- Liposomal injectable suspension
- Route
- Infiltration
- Packs
- 10 vials of 10 mL
- Manufacturer
- Jiangsu Hengrui Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store bupivacaine liposome injectable suspension vials refrigerated between 2° to 8°C (36° to 46°F). Do not re-refrigerate vials. Bupivacaine liposome injectable suspension may be held at a controlled room temperature of 20° to 25°C (68° to 77°F) for up to 30 days in sealed, intact (unopened) vials.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N01BB01 Bupivacaine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 July 2024
- Identifiers
- RxCUI 1191508, 1745061DailyMed set ID 0af296bb-1599-4b35-b66b-994924d3e898NDC 57884-3251Application ANDA214348
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 vial in 1 carton / 10 mL in 1 vial | 57884-3251-1 | Jiangsu Hengrui Pharmaceuticals | 1 July 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Bupivacaine 133 mg/10 mL liposomal injectable suspension.
Other strengths and forms of Bupivacaine
Clinical summary
Bupivacaine is an amide local anesthetic indicated in adults for the production of local or regional anesthesia or analgesia for surgery, dental and oral surgery procedures, diagnostic and therapeutic procedures, and for obstetrical procedures. MedsAcross supplies Bupivacaine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about BupivacaineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Marcaine prescribing information (Hospira) · U.S. National Library of Medicine, DailyMed
- Exparel liposomal: European public assessment report (EPAR) · European Medicines Agency
Need Bupivacaine 133 mg/10 mL liposomal injectable suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.